$ cat ./records/gates-champions-pepfar-the-bush-era-aids-program-as-a-model-for-g-2023.txt
Gates Champions PEPFAR, the Bush-Era AIDS Program, as a Model for Global Health
[RECORD.TXT] · cat --full
Bill Gates has been a prominent champion of the President's Emergency Plan for AIDS Relief (PEPFAR) — the global HIV/AIDS program launched by President George W. Bush in 2003 and credited with saving more than 25 million lives — holding it up as a model of effective, bipartisan foreign aid that the Gates Foundation has complemented with its own HIV work. In 2023, Gates joined Bush at a Bush Institute event marking PEPFAR's 20th anniversary to defend the program, and he has repeatedly warned that cuts to U.S. global-health funding would cost lives — an argument that sharpened amid later reductions in American aid.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Goes Public With Girlfriend Paula Hurd
Next →
Wall Street Journal Reports Epstein Allegedly Tried to Blackmail Gates Over a Past Relationship
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.